CJC-1295 & GHRP-6 Blend (10mg) Research Peptide: A Dual‑Pathway Synergistic Tool for Growth Hormone Studies

If your research explores the hypothalamic-pituitary-somatotropic axis, the dynamics of growth hormone (GH) secretion, or the metabolic effects of GH and IGF-1, the CJC-1295 & GHRP-6 Blend (10mg) research peptide offers a precisely defined, dual‑pathway experimental platform. This 10 mg formulation combines two mechanistically distinct yet complementary GH secretagogues—CJC-1295 (Mod GRF 1-29), a modified, short‑acting analogue of growth hormone‑releasing hormone (GHRH), and GHRP-6 (Growth Hormone Releasing Peptide-6), a potent ghrelin receptor agonist.

By simultaneously targeting the GHRH receptor and the growth hormone secretagogue receptor (GHS‑R1a), this blend allows researchers to model the synergistic interplay between sustained baseline stimulation and pulsatile bursts, providing deeper insight into the regulatory circuits that govern GH pulsatility and IGF‑1 signalling. Research has demonstrated that combining a GHRH analogue with a GHRP can produce GH responses 3 to 10 times greater than either compound alone. This makes the CJC-1295 & GHRP-6 Blend (10mg) research peptide a valuable tool for laboratories investigating GH regulation, metabolic research, and the complex interplay between GHRH and ghrelin signalling pathways.

At Chinese Grey Peptides, we supply high‑purity CJC-1295 & GHRP-6 Blend (10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥99% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into GH regulation, IGF‑1 signalling, and metabolic research begin with uncompromising quality.

What Is the CJC‑1295 & GHRP‑6 Blend and How Does It Work?

To fully appreciate the research potential of the CJC-1295 & GHRP-6 Blend (10mg) research peptide, it is essential to understand the distinct yet complementary mechanisms of its two components. Each peptide exploits a separate G‑protein‑coupled receptor (GPCR) with divergent downstream signalling, yet both ultimately converge on the somatotroph’s secretory machinery.

CJC-1295 (Mod GRF 1-29): The Short‑Acting GHRH Analogue

CJC‑1295 is a synthetic peptide derivative of growth hormone‑releasing hormone (GHRH), specifically a tetrasubstituted analogue of the N‑terminal 29 amino acids of hGRF(1‑29). Unlike CJC‑1295‑DAC, which contains a drug affinity complex (DAC) moiety and has an extended half‑life of approximately 6‑8 days, the version in this blend—CJC‑1295 without DAC (also called Modified GRF 1‑29)—does not contain the DAC moiety. It features four specific amino acid substitutions that confer resistance to enzymatic degradation and enhance bioactivity.

The absence of the DAC moiety is a deliberate design feature: CJC‑1295 without DAC has a biological half‑life of approximately 30 minutes and supports a more physiological pulsatile release pattern that closely mimics the body’s natural GH rhythm. CJC‑1295 activates GHRH receptors coupled to Gs proteins, driving adenylyl cyclase, cAMP accumulation, and PKA‑dependent GH gene transcription and granule exocytosis.

GHRP-6: The Potent Ghrelin Receptor Agonist

GHRP‑6 (Growth Hormone Releasing Peptide‑6) is a synthetic hexapeptide with the sequence His‑D‑Trp‑Ala‑Trp‑D‑Phe‑Lys‑NH₂. It acts as a ghrelin mimetic, binding to the growth hormone secretagogue receptor (GHS‑R1a), a GPCR expressed in the hypothalamus and pituitary.

GHRP‑6 engages the GHS‑R1a receptor coupled to Gq/11, triggering phospholipase C, inositol trisphosphate production, and intracellular calcium mobilization. It stimulates GH release through a mechanism that is independent of hypothalamic GHRH and somatostatin. GHRP‑6 also suppresses somatostatin and activates pituitary GHS‑R1a, creating a permissive environment for maximal GH pulse amplitude. A notable characteristic of GHRP‑6 is its significant appetite‑stimulating effect via ghrelin receptor activation, which may be relevant for research into feeding behaviour and metabolic regulation.

Mechanism of Synergy: Sustained Stimulation Meets Pulsatile Amplification

The scientific rationale for combining CJC‑1295 and GHRP‑6 lies in their convergent yet distinct mechanisms:

• CJC‑1295 provides sustained baseline GHRH‑receptor engagement via the cAMP/PKA signalling cascade, priming and sustaining the GH release signal.

• GHRP‑6 induces robust, rhythmic GH pulses through ghrelin receptor activation, amplifying the pulse amplitude.

GHRH + GHRP combinations produce GH release greater than the sum of either agent alone, with studies demonstrating that combining a GHRH analogue with a GHRP produces 2 to 5 times more growth hormone than either peptide alone. Bowers et al. demonstrated that combining GHRH with GHRP‑6 produced GH responses 3‑10 times greater than either compound alone in human subjects. The theorised synergy arises from sustained baseline GH stimulation via CJC‑1295, combined with pulsatile bursts from GHRP‑6, potentially creating a more dynamic and prolonged GH‑IGF‑1 milieu than either peptide alone.

Key Research Applications for the CJC‑1295 & GHRP‑6 Blend (10mg)

The CJC-1295 & GHRP-6 Blend (10mg) research peptide is a versatile tool with applications spanning several domains of endocrinological and metabolic research.

1. Growth Hormone Axis & Pituitary Function Studies

This blend provides a powerful model for investigating the hypothalamic‑pituitary‑somatotropic axis. Researchers can use it to study:

• The synergistic effects of GHRH and ghrelin pathway co‑activation on GH synthesis, storage, and pulsatile release

• The distinct contributions of GHRH‑mediated and ghrelin‑mediated signalling to overall GH secretion

• The dynamics of GH pulse amplitude and frequency in response to dual‑pathway stimulation

• The potential for sustained baseline receptor activity layered with pulsatile peaks to yield unique hormonal output patterns

GHRP‑6 stimulates GH secretion both by acting directly on the pituitary gland and indirectly via hypothalamic GRF, making it a valuable tool for studying pituitary and hypothalamic function.

2. Metabolic & Body Composition Research

By stimulating endogenous GH release through two pathways, this blend provides a model for studying the downstream metabolic effects of GH and IGF‑1 elevation. Research applications include:

• Lipid Metabolism: Exploring the role of GH in lipolysis and fat oxidation pathways

• Glucose Homeostasis: Investigating how GH modulation impacts glucose regulation and insulin sensitivity

• Body Composition: Studying how enhanced GH secretion may influence lean tissue accrual and adipose deposition

• Metabolic Disorders: Exploring the blend’s potential to inform research on obesity and insulin resistance

3. Appetite & Feeding Behaviour Research

GHRP‑6’s significant appetite‑stimulating effect via ghrelin pathway activation offers a distinct research angle. This blend can be used to study:

• The role of the ghrelin system in feeding behaviour, energy balance, and the neuroendocrine control of appetite

• The interaction between appetite‑stimulating signals and GH‑mediated metabolic effects

• Mass‑building models where appetite stimulation is specifically desired

4. Tissue Repair & Anabolic Signalling Research

GH and IGF‑1 are central to anabolic signalling cascades involved in protein synthesis and cellular growth. Research applications include:

• Muscle Cell Regeneration: Investigating the blend’s potential to support muscle tissue hypertrophy and protein deposition

• Connective Tissue Remodelling: Exploring the effects of amplified GH‑IGF‑1 signalling on collagen and extracellular matrix dynamics

• Bone and Skeletal Research: Investigating potential impacts on bone mineral content and skeletal development

5. Neuroendocrine & Receptor Pharmacology Research

The blend offers a multifaceted research modality for probing endogenous growth hormone axis mechanics. Researchers can use it to:

• Investigate the complex interplay between the GHRH and ghrelin systems

• Study the downstream signalling pathways activated by GHRH and ghrelin receptor co‑stimulation

• Characterise dual‑GPCR signalling (Gs and Gq/11) and second‑messenger outputs in the context of GH regulation

• Explore receptor bias and systems‑level integration within the organism

6. Neuroprotective & Cognitive Research

Emerging research has speculated that the peptide blend might support cognitive function by increasing the availability of GH and IGF‑1. Research applications include:

• Neuroprotection: Investigating GH‑mediated neuroprotective properties in degenerative research models

• Cognitive Function: Studying the potential impact of GH modulation on cognitive function and neuronal resilience

Chemical & Physical Specifications for CJC-1295 & GHRP-6 Blend (10mg)

Accurate characterisation of the CJC-1295 & GHRP-6 Blend (10mg) research peptide is essential for reproducible experimental design.

Note: The 10 mg mass represents the total peptide weight of the blend. The exact ratio of CJC‑1295 (Mod GRF 1‑29) to GHRP‑6 is determined by the formulation (contact for details). The blend is supplied in a single lyophilised vial. CJC‑1295 in this blend does not contain the Drug Affinity Complex (DAC) moiety. This product is intended strictly for in‑vitro and laboratory research use only (RUO). Not for human or animal use.

Reconstitution & Handling Protocol for the CJC‑1295 & GHRP‑6 Blend (10mg)

Proper reconstitution of the CJC-1295 & GHRP-6 Blend (10mg) research peptide is critical for maintaining the structural integrity and biological activity of both peptides.

Step 1 – Preparation

• Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 10 mg per 1 mL of diluent, yielding a 10 mg/mL total peptide concentration.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles.

• Once thawed, store at 2‑8°C and use within 14‑21 days.

Concentration Reference Table for CJC-1295 & GHRP-6 Blend (10mg)

Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is determined by the formulation’s component ratio.

Storage & Stability Guidelines for CJC-1295 & GHRP-6 Blend (10mg)

Why Choose Chinese Grey Peptides for the CJC‑1295 & GHRP‑6 Blend (10mg)?

As an authentic licensed peptide supplier based in the USA, we supply the CJC-1295 & GHRP-6 Blend (10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥99% for each component, every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO). This peptide blend is intended strictly for laboratory research, analytical, or reference use, where permitted by local regulations. Not for human or veterinary use.

Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: CJC‑1295 & GHRP‑6 Blend (10mg) Research Peptide

 What is the CJC-1295 & GHRP-6 Blend (10mg) research peptide?
It is a research‑grade formulation combining CJC‑1295 (Mod GRF 1‑29, a modified GHRH analogue without DAC) and GHRP‑6 (a potent ghrelin receptor agonist). It is used as a dual‑pathway tool to study growth hormone stimulation, IGF‑1 signalling, metabolic research, and appetite regulation.

 How does each component work?
CJC‑1295 (Mod GRF 1‑29) binds to GHRH receptors on pituitary somatotrophs via Gs‑coupled signalling, stimulating GH synthesis and release through the cAMP/PKA pathway. GHRP‑6 binds to the growth hormone secretagogue receptor (GHS‑R1a) via Gq/11‑coupled signalling, triggering phospholipase C and intracellular calcium mobilization. GHRP‑6 also suppresses somatostatin.

 What is the proposed synergy between CJC‑1295 and GHRP‑6?
CJC‑1295 provides sustained baseline GHRH‑receptor engagement and physiological GH pulsatility, while GHRP‑6 amplifies the response through the ghrelin receptor axis and suppresses somatostatin. GHRH + GHRP combinations produce GH responses 3‑10 times greater than either peptide alone.

 What distinguishes GHRP‑6 from other GHRPs in research?
GHRP‑6 generates the most intense appetite stimulation of any GHRP via ghrelin pathway activation, making it particularly useful for mass‑building and feeding behaviour research. It can also raise cortisol and prolactin slightly at higher doses.

 What is the difference between CJC‑1295 with DAC and without DAC?
CJC‑1295 without DAC (Mod GRF 1‑29) has a half‑life of approximately 30 minutes and supports a pulsatile release pattern that closely mimics natural physiology. CJC‑1295 with DAC has a half‑life of approximately 6‑8 days and produces sustained, continuous GH elevation.

 What purity does your CJC-1295 & GHRP-6 Blend (10mg) meet?
Each component is tested to ≥99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

 How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.

 How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 2‑8°C and used within 14‑21 days. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

 Is this peptide blend legal to purchase in the USA for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: CJC‑1295 and GHRP‑6 are not FDA‑approved for therapeutic use and are prohibited by the World Anti‑Doping Agency (WADA) for athletic use.

Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.

CJC-1295 & GHRP-6 Blend (10mg)

1. Shop Page
2. Bulk Orders Page
3. Contact Page
4. Shipping & Return Page
5. Peptide Purity Page

• PubChem CJC-1295
• PubChem GHRP-6
• FDA compounding-risk page for CJC-1295
• WADA Growth Hormone Releasing Factors Testing Guide
• Google Merchant Center structured data guidance
• Rank Math WooCommerce Product Schema

CJC-1295 & GHRP-6 Blend (10mg)

Ships to USA, Canada, UK & Europe

Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.

Shipping support may include:

• Order processing updates
• Packaging support
• Tracking information where available
• Wholesale shipment planning
• Destination-based shipping review
• Customer support during transit

Shipping times may vary by order size, carrier, destination, customs process, product status, and local requirements.

Why Choose Chinese Grey Peptides?

Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.

Customers choose us for:

• Professional peptide supplier support
• Small and wholesale order options
• Product documentation support
• HPLC testing information where available
• Mass Spectrum documentation where available
• International shipping support
• Responsive communication
• Clear order assistance before payment

We aim to make the buying process transparent, professional, and documentation-focused.

CJC-1295 & GHRP-6 Blend (10mg)

Important Compliance Notice

CJC-1295 GHRP-6 Blend 10mg may be regulated differently depending on the country, product type, labeling, intended use, buyer type, and destination. Chinese Grey Peptides does not provide medical advice, dosing instructions, injection guidance, growth hormone claims, anti-aging claims, fat-loss claims, muscle-growth claims, appetite claims, recovery claims, athletic-performance claims, bodybuilding claims, disease claims, treatment claims, or personal-use recommendations.

Customers are responsible for understanding and following all local laws, import rules, prescription requirements, compounding rules, sport-governing rules, labeling rules, and permitted-use requirements before ordering.

CJC-1295 & GHRP-6 Blend (10mg)

From its innovative design as a dual‑pathway GH secretagogue blend to its well‑documented role in modelling the synergistic interplay between the GHRH and ghrelin systems, the CJC-1295 & GHRP-6 Blend (10mg) research peptide provides a uniquely versatile platform for advanced endocrinological, metabolic, and appetite research.

Its ability to stimulate endogenous GH release through two distinct yet convergent pathways—CJC‑1295 providing sustained GHRH‑receptor engagement via cAMP/PKA signalling and GHRP‑6 amplifying through the ghrelin receptor axis via Gq/11 signalling while suppressing somatostatin—supported by research demonstrating synergistic GH responses 3‑10 times greater than either peptide alone, makes it a valuable addition to any laboratory investigating the GH/IGF‑1 axis, metabolic regulation, or feeding behaviour. By choosing high‑purity, lab‑verified CJC-1295 & GHRP-6 Blend (10mg) research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with the CJC-1295 & GHRP-6 Blend (10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the USA, UK, or Europe.CJC-1295 & GHRP-6 Blend (10mg)

CJC-1295 & GHRP-6 Blend (10mg),CJC-1295 & GHRP-6 Blend (10mg),CJC-1295 & GHRP-6 Blend (10mg),CJC-1295 & GHRP-6 Blend (10mg)